As the Trump administration erodes…
As the Trump administration erodes U.S. infrastructure supporting infectious disease [...]
Sanofi has reported mixed phase 3…
Sanofi has reported mixed phase 3 data on amlitelimab, further [...]
Bristol Myers Squibb added a big…
Bristol Myers Squibb added a big name to its executive [...]
Hoth Therapeutics has shared phase…
Hoth Therapeutics has shared phase 2 results on its treatment [...]
In a reminder of the money still…
In a reminder of the money still available for enticing [...]
Corcept Therapeutics’…
Corcept Therapeutics’ relacorilant has improved overall survival in a phase [...]
Bristol Myers Squibb will pay…
Bristol Myers Squibb will pay T-cell engager company Janux Therapeutics [...]
After a short delay and concerns…
After a short delay and concerns of potential intervention from [...]
Novo Nordisk has found a buyer for…
Novo Nordisk has found a buyer for cell therapy technologies [...]
Cancer imaging company Kuva Labs…
Cancer imaging company Kuva Labs is expanding its scope via [...]